Is syncope a predictor of mortality in acute pulmonary embolism?

Whether syncope as a presenting symptom independently classifies acute pulmonary embolism (APE) into a high mortality risk group remains a matter of controversy. We retrospectively included all consecutive patients admitted to our clinic with APE from January 2014 to December 2016. Our sample consisted of 76 patients with a mean age of 69 ±13.

Effects of neuromuscular electrical stimulation in patients with heart failure - review.

Research conducted in the last two decades suggests that neuromuscular electrical stimulation of the lower limb muscles (NMES) may be a "bridge" to conventional exercise or an alternative for patients with advanced chronic heart failure (CHF), non-compliant or non-responsive to physical training. Through stimulating the work of the skeletal muscles, NMES increases the functional capacity, muscle mass and endurance in patients with CHF. A beneficial effect of NMES on functional capacity, vascular endothelial function, quality of life and aerobic enzymes activity has been shown.

Clinical, biological, echocardiographic and therapeutic determinants of the length of hospital stay of patients with acute heart failure.

Hypothesis: The length of hospital stay (LOS) is a unanimously accepted measure of risk and treatment efficacy for in-patients.

Purpose: Our aim was to identify the parameters with predictive value for the LOS of patients with acute heart failure (AHF).

Methods: We analyzed 125 patients consecutively admitted to our clinic with a slight male predominance (54.

Metabolic syndrome and mean platelet volume variation in patients with chest pain and negative cardiac enzymes.

Introduction: The mean platelet volume (MPV) is an easily measurable parameter directly correlated with platelet aggregation function, proven to be increased in acute coronary syndromes, but also in the presence of cardiovascular risk factors such as the metabolic syndrome, dyslipidemia, diabetes mellitus, arterial hypertension.

Objective: This study intended to assess the role of the metabolic syndrome in MPV variation in patients presenting with chest pain.

Materials And Methods: We retrospectively analyzed data from 122 patients with chest pain and negative cardiac enzymes admitted consecutively to our clinic from September 1st 2011 to January 30th 2012.